|
| | Publication Year | Title | Author(s) |
| 281 | 10-Mar-2021 | EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism. | Gomez, Juliana; Areeb, Zammam; Stuart, Sarah F; Nguyen, Hong P T; Paradiso, Lucia; Zulkifli, Ahmad; Madan, Sonakshi; Rajagopal, Vijay; Montgomery, Magdalene K; Gan, Hui K ; Scott, Andrew M ; Jones, Jordan; Kaye, Andrew H; Morokoff, Andrew P; Luwor, Rodney B |
| 282 | Dec-2018 | Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold. | Arulananda, Surein; Mitchell, Paul L R |
| 283 | 2018 | Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies. | Brastianos, Priscilla K; Ippen, Franziska Maria; Hafeez, Umbreen ; Gan, Hui K |
| 4 | 28-Mar-2005 | Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. | Panousis, C; Rayzman, V M; Johns, T G; Renner, C; Liu, Z; Cartwright, Glenn A; Lee, Fook-Thean; Wang, D; Gan, Hui K ; Cao, D; Kypridis, A; Smyth, Fiona E; Brechbiel, Martin W; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M |
| 5 | Apr-2019 | Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2. | Barlesi, F; Drilon, A; De Braud, F; Cho, B C; Ahn, M J; Siena, S; Krebs, M G; Lin, C C; John, Thomas ; Tan, D S W; Seto, T; Dziadziuszko, R; Arkenau, H-T; Rolfo, C; Wolf, J; Ye, C; Riehl, T; Eng, S; Doebele, R C |
| 6 | Apr-2019 | Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001. | Paz-Ares, L; Doebele, R C; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, Thomas ; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Ye, C; Simmons, B; Demetri, G D |
| 7 | Feb-2020 | Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. | Doebele, Robert C; Drilon, Alexander; Paz-Ares, Luis; Siena, Salvatore; Shaw, Alice T; Farago, Anna F; Blakely, Collin M; Seto, Takashi; Cho, Byung Chul; Tosi, Diego; Besse, Benjamin; Chawla, Sant P; Bazhenova, Lyudmila; Krauss, John C; Chae, Young Kwang; Barve, Minal; Garrido-Laguna, Ignacio; Liu, Stephen V; Conkling, Paul; John, Thomas ; Fakih, Marwan; Sigal, Darren; Loong, Herbert H; Buchschacher, Gary L; Garrido, Pilar; Nieva, Jorge; Steuer, Conor; Overbeck, Tobias R; Bowles, Daniel W; Fox, Elizabeth; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Demetri, George D |
| 8 | Feb-2020 | Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials. | Drilon, Alexander; Siena, Salvatore; Dziadziuszko, Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; de Braud, Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jürgen; Seto, Takashi; Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas ; Goto, Koichi; Karapetis, Christos S; Arkenau, Hendrick-Tobias; Kim, Sang-We; Ohe, Yuichiro; Li, Yu-Chung; Chae, Young K; Chung, Christine H; Otterson, Gregory A; Murakami, Haruyasu; Lin, Chia-Chi; Tan, Daniel S W; Prenen, Hans; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Doebele, Robert C |
| 9 | 8-Nov-2006 | The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. | Gan, Hui K ; Walker, Francesca; Burgess, Antony W; Rigopoulos, Angela; Scott, Andrew M ; Johns, Terrance G |
| 10 | 27-Mar-2019 | Epidermal growth factor receptor (EGFR)-targeted therapies in Mesothelioma. | Chia, Puey Ling ; Scott, Andrew M ; John, Thomas |
| 11 | 20-Dec-2023 | The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. | Malta, Tathiane M; Sabedot, Thais S; Morosini, Natalia S; Datta, Indrani; Garofano, Luciano; Vallentgoed, Wies R; Varn, Frederick S; Aldape, Kenneth; D'Angelo, Fulvio; Bakas, Spyridon; Barnholtz-Sloan, Jill S; Gan, Hui K ; Hasanain, Mohammad; Hau, Ann-Christin; Johnson, Kevin C; Cazacu, Simona; deCarvalho, Ana C; Khasraw, Mustafa; Kocakavuk, Emre; Kouwenhoven, Mathilde C M; Migliozzi, Simona; Niclou, Simone P; Niers, Johanna M; Ormond, D Ryan; Paek, Sun Ha; Reifenberger, Guido; Sillevis Smitt, Peter A; Smits, Marion; Stead, Lucy F; van den Bent, Martin J; Van Meir, Erwin G; Walenkamp, Annemiek; Weiss, Tobias; Weller, Michael; Westerman, Bart A; Ylstra, Bauke; Wesseling, Pieter; Lasorella, Anna; French, Pim J; Poisson, Laila M; Consortium, The Glass; Verhaak, Roel G W; Iavarone, Antonio; Noushmehr, Houtan |
| 12 | 12-Dec-2013 | Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. | Jonker, D J; Karapetis, C S; Harbison, C; O'Callaghan, Christopher J ; Tu, D; Simes, R J; Malone, D P; Langer, C; Tebbutt, Niall C ; Price, Timothy J; Shapiro, J; Siu, L L; Wong, R P W; Bjarnason, G; Moore, M J; Zalcberg, John R; Khambata-Ford, S |
| 13 | 23-May-2022 | Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. | Luk, Ian Y; Jenkins, Laura J; Schoffer, Kael L; Ng, Irvin; Tse, Janson W T; Mouradov, Dmitri; Kaczmarczyk, Stanislaw; Nightingale, Rebecca; Burrows, Allan D; Anderson, Robin L ; Arango, Diego; Dopeso, Higinio; Croft, Larry; Richardson, Mark F; Sieber, Oliver M; Liao, Yang; Mooi, Jennifer K ; Vukelic, Natalia; Reehorst, Camilla M; Afshar-Sterle, Shoukat ; Whitehall, Vicki L J; Fennell, Lochlan; Abud, Helen E; Tebbutt, Niall C ; Phillips, Wayne A; Williams, David S ; Shi, Wei; Mielke, Lisa A; Ernst, Matthias ; Dhillon, Amardeep S; Clemons, Nicholas J; Mariadason, John M |
| 14 | 23-Oct-2008 | Established, emerging and future roles of PET/CT in the management of colorectal cancer. | Herbertson, R A; Scarsbrook, A F; Lee, S T; Tebbutt, Niall C ; Scott, Andrew M |
| 15 | 2-Jul-2014 | Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: a randomized trial in adult haematology patients with Hickman devices. | Worth, Leon J; Slavin, M A; Heath, S; Szer, J; Grigg, Andrew P |
| 16 | Jan-2023 | Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database. | Margalit, Ofer; Harmsen, William S; Shacham-Shmueli, Einat; Voss, Molly M; Boursi, Ben; Wagner, Anna D; Cohen, Romain; Olswold, Curtis L; Saltz, Leonard B; Goldstein, Daniel A; Hurwitz, Herbert; Tebbutt, Niall C ; Kabbinavar, Fairooz F; Adams, Richard A; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef |
| 17 | 26-Dec-2023 | Evaluating the Educational Value of Cancer Registries - a Systematic Review and Thematic Analysis. | Lin, James; Temperley, Hugo C; Larkins, Kirsten; Waters, Caitlin; Chong, Kit Loong; Maida, Jack; Proud, David ; Burgess, Adele N ; Heriot, Alexander; Smart, Philip J ; Mohan, Helen |
| 18 | 7-Mar-2023 | Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial. | Gupta, Arjun; O'Callaghan, Christopher J ; Zhu, Liting; Jonker, Derek J; Wong, Ralph P W; Colwell, Bruce; Moore, Malcolm J; Karapetis, Christos S; Tebbutt, Niall C ; Shapiro, Jeremy D; Tu, Dongsheng; Booth, Christopher M |
| 19 | Apr-2023 | Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment. | Cox, Daniel R A ; Chung, William ; Grace, Josephine A ; Wong, Darren; Kutaiba, Numan ; Ranatunga, Dinesh G ; Khor, Richard ; Perini, Marcos V ; Fink, Michael A ; Jones, Robert M ; Goodwin, Mark D ; Dobrovic, Alex; Testro, Adam G ; Muralidharan, Vijayaragavan |
| 20 | 1-Aug-2002 | Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. | Hannah, Anthony; Scott, Andrew M ; Tochon-Danguy, Henri; Chan, J Gordon ; Akhurst, Tim; Berlangieri, Salvatore U ; Price, David; Smith, Gerard J; Schelleman, Tony; McKay, W J; Sizeland, Andrew |
